Investments (Tables)

9 Months Ended

Sep. 30, 2020

Equity Method Investments and Joint Ventures [Abstract]

Equity Method Investments

The Company used the following summarized financial information for NantOmics for the nine months ended June 30, 2020, and the three and nine months ended June 30, 2019, to record its equity method losses for the nine months ended September 30, 2020 and the three and nine months ended September 30, 2019:

	Three Months Ended June 30,		Nine Months Ended June 30,
	2019		2020		2019
Revenues	$	847	$	349	$	3,913
Gross loss	(1,239)		(1,641)		(2,573)
Loss from operations	(4,436)		(7,806)		(17,541)
Impairment on equity investments	—		—		(12,265)
Net loss	(3,333)		(2,618)		(26,263)
Net loss attributable to NantOmics	(3,296)		(2,559)		(26,005)